Biotech Values

[bladerunner1717]

It's intersting that RGEN is up today. It may be explained by the fact that the results were already factored into the stock price. Dr. Garren had been predicting that Secretin would not work in any indication, yet he has it in his model portfolio and has been adding recently. His reasoning is that BMY's drug for rheumatoid arthritis (RA), and multiple sclerosis (MS) will be a hige success, and will be launched before the end of the year. Garren says that RGEN's use patents are solid in these areas and BMY will shortly be forced to deal with RGEN or be faced with a court trial where BMT is almost certain to lose and, thus, will have to pay higher royalties than the 3% that Garren is predicting RGEN would get now in a settlement.

Garren says that RGEN has an even stronger case against Imclone on Erbitux and is sure to get some money on sales already on Erbitux.

Garren said the time to buy would be upon the release of what he predicted would be negative results in the schizophrenia trials. However, I'm quite certain he didn't expect the stock price to go UP on the release of those negative results.

Since I don't know the science or the law here, I'd appreciate comments from the board.


Bladerunner


Bladerunner